当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2016年第12期
编号:12856584
宫颈癌术后调强放疗的效果(5)
http://www.100md.com 2016年4月25日 《中国医药导报》 2016年第12期
     [15] Van de Bunt L,van de Heide UA,Ketelaars M,et al. Conventional,conformal,and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer:the impact of tumor regression [J]. Int J Radiat Oncol Biol Phys,2006,64(1):189-196.

    [16] Mell LK,Kochanski JD,Roeske JC,et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy [J]. Int J Radiat Oncol Biol Phys,2006,66(5):1356.

    [17] Warren D,Souza D,Anesa A,et al. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma [J].Int J Radiat Ontol Biol Phys,2005,61(4):1062-1070.

    [18] Mundt AJ,Mell LK,Roeske JC. Preliminary analysis of chronicgastro-intestinal toxicity in Gynecolo Gy patients treated with intensity-modulated whole pelvic radiation therapy [J]. Int J Radiat Oncol Biol Phys,2003,56(5):1354-1360.

    (收稿日期:2016-01-16 本文编辑:任 念), http://www.100md.com(方绳权 陈海燕 高敏 熊世禄 张慧峰 杨润峰)
上一页1 2 3 4 5